New immunotherapy shows promise against rare childhood cancer
- OPACC
- Nov 30, 2020
- 1 min read
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer.
Comments